Our Life Sciences business leverages cutting-edge deep-freezing technologies, culture control and biosensing innovations, and reagent development capabilities to provide innovative clinical and research laboratory solutions. These include indispensable equipment for long-term sample storage and stable cell culture, precision technology for cell and gene therapy (CGT), as well as diagnostic instruments and testing/analysis devices. Through this extensive product lineup, we support the advancement and efficiency of life sciences research, as well as the delivery of precise, rapid diagnostics in medical practice.

Amid the increase in cancer cases and progress in advanced medical treatments, including personalized medicine, we seek to help achieve earlier, more precise, and more accessible cancer diagnostics, as well as the early adoption of new treatments. Our focus is on developing new solutions to improve diagnostic efficiency and accuracy, enhance productivity in cell therapy manufacturing, and reduce treatment and manufacturing costs.

---

LiCellMo also received the 2024 Innovation Award from The Analytical Scientist.
> For Details

---

Voices from the frontlines